Literature DB >> 10574779

Expressed protein ligation to probe regiospecificity of heterocyclization in the peptide antibiotic microcin B17.

R S Roy1, O Allen, C T Walsh.   

Abstract

BACKGROUND: The Escherichia coli peptide antibiotic microcin B17 (MccB17) contains thiazole and oxazole heterocycles derived from a distributive yet directional cyclization of cysteines and serines in the McbA precursor catalyzed by MccB17 synthetase. Whether the formation of upstream rings potentiates downstream heterocyclization has not been previously determined.
RESULTS: McbA fragments (46-61 residues) containing glycine substitutions or homocysteine at select upstream cysteine or serine sites were assembled using expressed protein ligation (EPL). Most of these substrates were only partially cyclized by MccB17 synthetase, in contrast to the efficient processing of wild-type McbA(1-61). Homocysteine was not processed to the six-membered heterocycle.
CONCLUSIONS: The formation of upstream rings in McbA potentiates the cyclization of carboxy-terminal cysteines and serines, probably by selecting against unfavorable substrate conformations. EPL allows structure-function analysis including unnatural amino acid placements to probe the regiospecificity and chemoselectivity of post-translational heterocyclization during antibiotic maturation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10574779     DOI: 10.1016/s1074-5521(99)80126-4

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  14 in total

1.  Selectivity, directionality, and promiscuity in peptide processing from a Bacillus sp. Al Hakam cyclodehydratase.

Authors:  Joel O Melby; Kyle L Dunbar; Nhat Q Trinh; Douglas A Mitchell
Journal:  J Am Chem Soc       Date:  2012-03-08       Impact factor: 15.419

Review 2.  Chemoenzymatic Semisynthesis of Proteins.

Authors:  Robert E Thompson; Tom W Muir
Journal:  Chem Rev       Date:  2019-11-27       Impact factor: 60.622

3.  Three ring posttranslational circuses: insertion of oxazoles, thiazoles, and pyridines into protein-derived frameworks.

Authors:  Christopher T Walsh; Steven J Malcolmson; Travis S Young
Journal:  ACS Chem Biol       Date:  2012-01-17       Impact factor: 5.100

Review 4.  Streptolysin S-like virulence factors: the continuing sagA.

Authors:  Evelyn M Molloy; Paul D Cotter; Colin Hill; Douglas A Mitchell; R Paul Ross
Journal:  Nat Rev Microbiol       Date:  2011-08-08       Impact factor: 60.633

5.  Engineering unnatural variants of plantazolicin through codon reprogramming.

Authors:  Caitlin D Deane; Joel O Melby; Katie J Molohon; Aziz R Susarrey; Douglas A Mitchell
Journal:  ACS Chem Biol       Date:  2013-07-03       Impact factor: 5.100

6.  Expressed protein ligation-mediated template protein extension.

Authors:  Ayako Kamei; Paul S Hauser; Jennifer A Beckstead; Paul M M Weers; Robert O Ryan
Journal:  Protein Expr Purif       Date:  2012-04-01       Impact factor: 1.650

7.  Semisynthesis and segmental isotope labeling of the apoE3 N-terminal domain using expressed protein ligation.

Authors:  Paul S Hauser; Vincent Raussens; Taichi Yamamoto; Gezman E Abdullahi; Paul M M Weers; Brian D Sykes; Robert O Ryan
Journal:  J Lipid Res       Date:  2008-12-19       Impact factor: 5.922

8.  Insights into the mechanism of peptide cyclodehydrations achieved through the chemoenzymatic generation of amide derivatives.

Authors:  Kyle L Dunbar; Douglas A Mitchell
Journal:  J Am Chem Soc       Date:  2013-05-30       Impact factor: 15.419

9.  Modulating the Copper-Sulfur Interaction in Type 1 Blue Copper Azurin by Replacing Cys112 with Nonproteinogenic Homocysteine.

Authors:  Kevin M Clark; Yang Yu; Wilfred A van der Donk; Ninian Blackburn; Yi Lu
Journal:  Inorg Chem Front       Date:  2014-02-01       Impact factor: 6.569

10.  Structural and functional dissection of the heterocyclic peptide cytotoxin streptolysin S.

Authors:  Douglas A Mitchell; Shaun W Lee; Morgan A Pence; Andrew L Markley; Joyce D Limm; Victor Nizet; Jack E Dixon
Journal:  J Biol Chem       Date:  2009-03-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.